serplulimab,Atezolizumab,Carboplatin,Etoposide,Tiragolumab
fosun pharmaceuticals,roche
['lcsm,(-blcsm)', 'sclc']
putting results of #astrum-005 and #skyscraper-o2 into perspective - bringing the median os w/ serplu 15.4 months! no significant improvement with tira
once again, #sclc remains tough to tackle
#lcsm #asco22 
Leslye M. Heisler Associate Professor of Lung Cancer Excellence @PennMedicine | Faculty @PC31 | Associate Director @PennPrecisMed | Tweets my own